跳至主要内容
临床试验/TCTR20240711001
TCTR20240711001尚未招募3 期

Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical Trial

Thai Health Promotion Foundation0 个研究点目标入组 120 人开始时间: 2024年7月11日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • •1. Over 18 years of age and not over 65 years of age.
  • •2. Current daily cigarette smokers. There is a need to quit smoking at the preparation/contemplation level according to The Trans theoretical Model.
  • •3. Sign the Informed Consent Form.
  • •4. Smoke more than 10 cigarettes per day.
  • •5. If you are a woman of reproductive age and have a chance of becoming pregnant Must be willing to use birth control before participating in the research project. 6. Have a mobile phone that can set reminders and allow the use of telephone reminder methods. For use in evaluating drug compliance of volunteers

排除标准

  • •1. Have a congenital disease that may be dangerous from receiving research drugs, such as heart arrhythmia. Coronary artery disease, cancer, chronic kidney disease (creatinine clearance <30 ml/minute), psychiatric disorders such as depression. schizophrenia or patients who also use other types of drugs such as marijuana, amphetamines, etc.
  • •2. Are pregnant or breastfeeding
  • •3. Already being treated with medications to help you quit smoking, including nicotine replacement therapy (NRT), Nortriptyline, Bupropion, Clonidine, and Varenicline.

研究者

相似试验